Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 49 for “"Ezetimibe"”.

  1. Εφαρμογή πληθυσμιακών φαρμακοκινητικών μεθόδων σε δεδομένα μελέτης του ezetimibe

    Εισαγωγή Το ezetimibe αποτελεί ένα αντιυπερλιπιδαιμικό φάρμακο, το οποίο διαθέτει διαφορετικό μηχανισμό δράσης από τις υπόλοιπες κατηγορίες φαρμάκων, οι οποίες χρησιμοποιούνται για τη μείωση της χοληστερόλης στο πλάσμα, καθώς αναστέλλει εκλεκτικά την εντερική απορρόφηση της χοληστερόλης και των …

    athens Repository record for Εφαρμογή πληθυσμιακών φαρμακοκινητικών μεθόδων σε δεδομένα μελέτης του ezetimibe (opens in a new tab)

  2. The effects of ezetimibe on omega-3 fatty acid absorption in the prevention of cardiovascular disease

    … determine if a cholesterol absorption inhibitor, ezetimibe, decreases circulating levels of ALA in humans. Patients were randomly assigned to one of four groups for a 6 weeks: 1) placebo; 2) ezetimibe therapy (10mg); 3) flaxseed oil (containing 1.0g ALA); or 4) ezetimibe and flaxseed oil …

    manitoba Repository record for The effects of ezetimibe on omega-3 fatty acid absorption in the prevention of cardiovascular disease (opens in a new tab)

  3. The effect of hypolipidaemic treatment on oxidized phospholipids of lipoprotein (a)

    … high-intensity statin monotherapy (n=28), ezetimibe added to high-intensity statin (n=31), and PCSK9 inhibitor added to high-intensity statin plus ezetimibe (n=11). Follow-up duration was 3 months. Results: Mean age was 51 ± 15 years, 40% were male, 39% were diagnosed with HeFH, 16% with …

    greece Repository record for The effect of hypolipidaemic treatment on oxidized phospholipids of lipoprotein (a) (opens in a new tab)

  4. Σύγκριση πλειοτροπικών δράσεων υπολιπιδαιμικών θεραπειών

    … or the combination of low-dose statin with ezetimibehave comparable pleiotropic effects is unknownAim: The aim οf this thesis was to compare the effects of different statins or thecombination of a statin with ezetimibe at equivalent low-density lipoprotein cholesterollowering doses on …

    greece Repository record for Σύγκριση πλειοτροπικών δράσεων υπολιπιδαιμικών θεραπειών (opens in a new tab)

  5. Ensaio clínico sobre o impacto da inibição de um transportador de membrana do colesterol na absorção da vitamina D

    … até o momento. Objetivo: Avaliar o impacto do ezetimibe na absorção da vitamina D em indivíduos saudáveis e, com isso, determinar se o transportador de colesterol Niemann–Pick C1-Like 1 participa deste processo. Métodos: Ensaio clínico randomizado, controlado e duplo-cego (ClinicalTrials.gov: …

    brazil-ufrgs Repository record for Ensaio clínico sobre o impacto da inibição de um transportador de membrana do colesterol na absorção da vitamina D (opens in a new tab)

  6. Hacia la individualización del tratamiento con estatinas en la Enfermedad Renal Crónica

    … eficacia del tratamiento con estatinas con/sin ezetimibe y la reducción en los niveles de colesterol LDL y proteína C reactiva (PCR) en la población con enfermedad renal crónica (ERC). En el metanálisis pareado, las estatinas con o sin ezetimibe son eficaces para reducir la aparición de nuevos …

    valladolid Repository record for Hacia la individualización del tratamiento con estatinas en la Enfermedad Renal Crónica (opens in a new tab)

  7. Επίδραση υπολιπιδαιμικών φαρμάκων στη μάζα της Lp-PLA2 και σε άλλους δείκτες φλεγμονής σε άτομα με πρωτοπαθή υπερλιπιδαιμία

    … of lipid-lowering drugs like statins, fibrates, ezetimibe, bile acid binding resins, nicotinic acid and omega-3 fatty acids. Each of these drugs affects the metabolism of lipids through different ways and exerts various results in the reduction of both the lipoprotein levels and the risk for …

    greece Repository record for Επίδραση υπολιπιδαιμικών φαρμάκων στη μάζα της Lp-PLA2 και σε άλλους δείκτες φλεγμονής σε άτομα με πρωτοπαθή υπερλιπιδαιμία (opens in a new tab)

  8. Pharmacokinetic analysis of studies with emphasis on drug distribution and absorption from lungs and the gastrointestinal system

    … complex distribution processes of a drug (total ezetimibe, free ezetimibe, and its metabolite) undergoing first-pass metabolism and enterohepatic re-circulation. In total, seven individual analyses are presented in this thesis, in an effort to further expand our understanding on the application …

    greece Repository record for Pharmacokinetic analysis of studies with emphasis on drug distribution and absorption from lungs and the gastrointestinal system (opens in a new tab)

  9. Η επίδραση της επιθετικής υπολιπιδαιμικής αγωγής σε αγγειακούς ασθενείς που υποβάλλονται σε χειρουργική θεραπεία

    … or intensified by combining statin with ezetimibe on a 12-month prognosis after vascular surgery. Methods: Patients were randomly assigned to receive rosuvastatin (RSV) 10 mg/d or rosuvastatin 10 mg/d plus ezetemibe (RSV/EZT) 10 mg/d, starting prior to scheduled surgical procedure. The …

    greece Repository record for Η επίδραση της επιθετικής υπολιπιδαιμικής αγωγής σε αγγειακούς ασθενείς που υποβάλλονται σε χειρουργική θεραπεία (opens in a new tab)

  10. Ανάπτυξη μεθόδου εκχύλισης προσρόφησης σε υφασμάτινο μέσο με πειραματικό σχεδιασμό για την ανάλυση στατινών και εζετιμίμπης σε ανθρώπινο πλάσμα με LC-ESI-MS/MS

    … αποτελούν την κύρια κατηγορία φαρμάκων, ενώ το ezetimibe, ένας νεότερος αναστολέας, μειώνει την απορρόφηση της χοληστερόλης. Στο πλαίσιο της παρούσας διπλωματικής εργασίας, αναπτύχθηκε και βελτιστοποιήθηκε μια μέθοδος εκχύλισης προσρόφησης σε υφασμάτινο μέσο (FPSE) για την ανάλυση δειγμάτων …

    athens Repository record for Ανάπτυξη μεθόδου εκχύλισης προσρόφησης σε υφασμάτινο μέσο με πειραματικό σχεδιασμό για την ανάλυση στατινών και εζετιμίμπης σε ανθρώπινο πλάσμα με LC-ESI-MS/MS (opens in a new tab)

  11. PCSK9 inhibitors as a therapy for hypercholesterolemia

    … for hypercholesterolemia, such as statins or ezetimibe, and are equivalent in efficacy with high dose statins. Investigation of PCSK9 inhibitors through siRNA may provide additional mechanisms for lowering cholesterol in the future.

    bu Repository record for PCSK9 inhibitors as a therapy for hypercholesterolemia (opens in a new tab)

  12. Cardiovascular risk in HIV-positive patients : assessment and pharmacological treatment

    … 10 mg: increasing the dose to 20 mg or adding ezetimibe 10 mg to ongoing rosuvastatin. Findings of the cohort study included a unique and unexpected pattern of treatment-associated lipid abnormalities in HIV+ patients initiating therapy with non-nucleoside reverse transcriptase inhibitors. A …

    ubc Repository record for Cardiovascular risk in HIV-positive patients : assessment and pharmacological treatment (opens in a new tab) Download PDF for Cardiovascular risk in HIV-positive patients : assessment and pharmacological treatment (opens in a new tab)

  13. Novel Methods of Mycobacterial Control via Manipulation of Host Lipid Bioavailability

    … lipids during early infection via treatment with ezetimibe, an FDA-approved drug, resulted in a reduction of bacterial growth in vivo. The effect of ezetimibe in reducing bacterial growth was dependent on the mce4 operon, a key bacterial determinant of lipid utilization. Thus, in vivo, lipid …

    duke Repository record for Novel Methods of Mycobacterial Control via Manipulation of Host Lipid Bioavailability (opens in a new tab)

  14. Pediatric Physiologically Based Pharmacokinetic (PBPK) Modeling to Advance Knowledge of Breastfeeding Infant Exposure to Maternal Medications

    … taking lamotrigine, cannabidiol (CBD), and ezetimibe, (2) identify potential maternal factors that may impact concentrations of drugs in milk for incorporation into the workflow established in objective 1 for CBD, and (3) optimize the utility of the novel metric for use in clinical practice. …

    waterloo Repository record for Pediatric Physiologically Based Pharmacokinetic (PBPK) Modeling to Advance Knowledge of Breastfeeding Infant Exposure to Maternal Medications (opens in a new tab)

  15. IDENTIFYING THE MECHANISMS OF LYMPH NODE HYPERTROPHY IN ATHEROSCLEROTIC MICE

    … apoE-/- mice with the cholesterol lowering drug Ezetimibe ameliorated lymph node hypertrophy and leads to a partial restoration of cellular egress through changes in the lymph node microenvironment.

    nus Repository record for IDENTIFYING THE MECHANISMS OF LYMPH NODE HYPERTROPHY IN ATHEROSCLEROTIC MICE (opens in a new tab) Download file for IDENTIFYING THE MECHANISMS OF LYMPH NODE HYPERTROPHY IN ATHEROSCLEROTIC MICE (opens in a new tab)

Page 1 of 3